Skip to content
My WebMD Sign In, Sign Up

Birth Control Health Center

Font Size

FDA: Stronger Labeling Needed for Newer Contraceptives

Dangerous Blood-Clot Risks Need to Be More Prominent on Future Labels

Labeling Changes May Be Needed

Although the panel voted to keep the newer pills on the market, there was a strong divide among the experts.

Panelist Almut Winterstein, PhD, associate professor at the University of Florida College of Pharmacy, said the data also suggest Yasmin users are younger and healthier, so the increased risk of blood clots might actually be higher than the research has found. All birth control pills that contain estrogen and a progestin, including drospirenone, have a boxed warning on their labels about the risk of serious heart and blood-vessel problems such as blood clots in smokers over age 35.

The panel was nearly unanimous in saying the label on drospirenone contraceptives should explain even more clearly that some studies suggest they increase the risk of blood clots. But panelists questioned how to make that information comprehensible to doctors, let alone patients.

The FDA has not set a date to discuss the wording of the new labels.

1|2

Today on WebMD

Birth Control Options
Slideshow
mother and daughter talking
Evaluator
 
Period Questions
Slideshow
Condom Quiz
Quiz
 
Forgot To Take Your Birth Control Pills
Article
pelivic pain slideshow
Slideshow
 
Birth Control Pills Weight Gain
Article
Ortho Evra Birth Control Patch
Article
 
Comparing Birth Control Pill
Article
New Birth Control Pill
Video
 
HPV Vaccine Future
Article
Young couple holding hands
Quiz